These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22543547)

  • 21. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
    Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E
    BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity?
    Haylen BT; Chetty N; Logan V; Schulz S; Verity L; Law M; Zhou J
    Int Urogynecol J Pelvic Floor Dysfunct; 2007 Feb; 18(2):123-8. PubMed ID: 16823541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Female Urgency, Trial of Urodynamics as Routine Evaluation (FUTURE study): a superiority randomised clinical trial to evaluate the effectiveness and cost-effectiveness of invasive urodynamic investigations in management of women with refractory overactive bladder symptoms.
    Abdel-Fattah M; Chapple C; Guerrero K; Dixon S; Cotterill N; Ward K; Hashim H; Monga A; Brown K; Drake MJ; Gammie A; Mostafa A; Bladder Health UK; Breeman S; Cooper D; MacLennan G; Norrie J
    Trials; 2021 Oct; 22(1):745. PubMed ID: 34702331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which method is the most reliable in determination of bladder capacity in children with idiopathic overactive bladder? A comparison of maximum voided volume, uroflowmetry and maximum cystometric capacity.
    Uluocak N; Oktar T; Ander H; Ziylan O; Acar O; Rodoplu H; Erkormaz U
    J Pediatr Urol; 2009 Dec; 5(6):480-4. PubMed ID: 19342301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there concordance between overactive bladder and detrusor overactivity in men with predominant storage urinary symptoms referred to Functional Urology and Urodynamics Units?
    Esteban-Fuertes M; Prieto-Chaparro L; Arlandis-Guzmán S; Salinas-Casado J; Gago-Ramos JL;
    Actas Urol Esp (Engl Ed); 2022; 46(1):41-48. PubMed ID: 34848162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of transobturator tape treatment on overactive bladder symptoms, particularly nocturia, in patients with mixed urinary incontinence.
    Lee SK; Kang HW; Kim WT; Kim YJ; Yun SJ; Lee SC; Kim WJ
    Korean J Urol; 2014 Aug; 55(8):520-6. PubMed ID: 25132946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasound measurement of bladder wall thickness is associated with the overactive bladder syndrome.
    Panayi DC; Tekkis P; Fernando R; Hendricken C; Khullar V
    Neurourol Urodyn; 2010 Sep; 29(7):1295-8. PubMed ID: 20127835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and predictors of overactive bladder in nonpregnant nulliparous women below 65 years of age.
    Robinson D; Åkervall S; Wagg A; Chapple C; Milsom I; Gyhagen M
    Int Urogynecol J; 2018 Apr; 29(4):531-537. PubMed ID: 28779415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
    Lai H; Gardner V; Vetter J; Andriole GL
    BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypersensitive or Detrusor Overactivity: Which is Associated with Filling Symptoms in Female Bladder Outlet Obstructed Patients.
    Zhang J; Cao M; Chen Y; Liang W; Liang Y
    Urol J; 2019 Jun; 16(3):285-288. PubMed ID: 30882167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nocturnal Urinary Disorders and Multiple Sclerosis: Clinical and Urodynamic Study of 309 Patients.
    Mauruc E; Guinet-Lacoste A; Falcou L; Manceau P; Verollet D; Le Breton F; Amarenco G
    J Urol; 2017 Feb; 197(2):432-437. PubMed ID: 27816615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective randomized trial comparing the use of tolterodine or weighted vaginal cones in women with overactive bladder syndrome.
    Yüce T; Dökmeci F; Çetinkaya ŞE
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():91-7. PubMed ID: 26720597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the overactive bladder symptom score and the overactive bladder symptom score derived from the bladder diaries.
    Hikita KS; Honda M; Hirano S; Kawamoto B; Panagiota T; Muraoka K; Sejima T; Takenaka A
    Neurourol Urodyn; 2016 Mar; 35(3):349-53. PubMed ID: 25597478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiological aspects of nocturia in a danish population of men and women age 60 to 80 years.
    Bing MH; Moller LA; Jennum P; Mortensen S; Lose G
    J Urol; 2007 Aug; 178(2):552-7. PubMed ID: 17570415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond the bladder: poor sleep in women with overactive bladder syndrome.
    Savoie MB; Lee KA; Subak LL; Hernandez C; Schembri M; Fung CH; Grady D; Huang AJ
    Am J Obstet Gynecol; 2020 Jun; 222(6):600.e1-600.e13. PubMed ID: 31836545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bladder diary patterns in detrusor overactivity and urodynamic stress incontinence.
    Parsons M; Amundsen CL; Cardozo L; Vella M; Webster GD; Coats AC;
    Neurourol Urodyn; 2007; 26(6):800-6. PubMed ID: 17335054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of Bladder Filling Rate on the Voiding Behavior of Patients with Overactive Bladder.
    Redmond EJ; O'Kelly T; Flood HD
    J Urol; 2019 Aug; 202(2):326-332. PubMed ID: 30817239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daily symptom associations for urinary urgency and anxiety, depression and stress in women with overactive bladder.
    Mehr AA; Kreder KJ; Lutgendorf SK; Ten Eyck P; Greimann ES; Bradley CS
    Int Urogynecol J; 2022 Apr; 33(4):841-850. PubMed ID: 34842938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urethral dilatation: Is there any benefit over cystoscopy and distension? A randomized trial in women with overactive bladder symptoms.
    Basu M; Khullar V; Duckett J
    Neurourol Urodyn; 2014 Mar; 33(3):283-8. PubMed ID: 23636866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study).
    Herschorn S; Chapple CR; Abrams P; Arlandis S; Mitcheson D; Lee KS; Ridder A; Stoelzel M; Paireddy A; van Maanen R; Robinson D
    BJU Int; 2017 Oct; 120(4):562-575. PubMed ID: 28418102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.